SMTL ID : 2qlq.2 (1 other biounit)

Crystal structure of SRC kinase domain with covalent inhibitor RL3

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.33 Å

Oligo State

monomer

Ligands

1 x SR2: (2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide(Covalent)

SR2.1: 13 residues within 4Å: Chain A: V.34, A.46, K.48, I.89, T.91, M.94, G.97, C.98, L.100, D.101, A.143, L.146, D.157 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:V.34, A:L.146 Hydrogen bonds: A:M.94 Salt bridges: A:D.101 Halogen bonds: A:I.89

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Michalczyk, A. et al., Structural insights into how irreversible inhibitors can overcome drug resistance in EGFR. Bioorg.Med.Chem. (2008)

Release Date

2008-03-11

Peptides

Proto-oncogene tyrosine-protein kinase Src: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Proto-oncogene tyrosine-protein kinase Src

Related Entries With Identical Sequence